Follow the 파마리서치바이오 share price and the full insider trade history of the company, a listed equity based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 파마리서치바이오 has logged 11 insider filings. Market capitalisation: €128.4bn. The latest transaction was reported on 4 March 2026 (Sale). Among the most active insiders: 신한캐피탈. Every trade is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
11 of 11 declarations